Assoc. Prof. Dr. Adelaida Lamas Ferreiro | Antibiotic | Best Researcher Award

Assoc. Prof. Dr. Adelaida Lamas Ferreiro | Antibiotic | Best Researcher Award

Associate Professor at Ramon y Cajal University Hospital, Madrid, Spain

Adelaida Lamas Ferreiro has built a distinguished career in pediatric pulmonology with a focus on cystic fibrosis and infectious respiratory diseases. Throughout her professional timeline, her pioneering efforts in the study and application of Antibiotic therapies have made significant impacts on clinical outcomes. Her leadership in both hospital settings and international consortia has cemented her role in optimizing Antibiotic use in cystic fibrosis care. She has evaluated Antibiotic efficiency in respiratory complications and promoted Antibiotic stewardship in pediatric medicine. With more than 50 clinical trials and academic projects centered on Antibiotic strategies, Adelaida’s research continuously reinforces Antibiotic relevance in managing chronic pulmonary conditions, particularly within vulnerable pediatric populations requiring advanced Antibiotic interventions.

Professional Profile 

Google Scholar

Education

Adelaida Lamas holds a Ph.D. in Medicine and Surgery from Universidad Autónoma de Madrid with academic excellence in pediatric sedation monitoring. Her postgraduate qualifications include a master’s degree in pulmonology unit management and another in clinical hospital administration. From early stages, her education was deeply influenced by studies on Antibiotic action in pulmonary systems. She has pursued extensive training on Antibiotic pharmacodynamics, pharmacokinetics, and Antibiotic mechanisms of resistance. Her international clinical rotations emphasized Antibiotic treatment in cystic fibrosis, reinforcing her expertise in tailoring Antibiotic protocols. Her educational path consistently aligned with evolving Antibiotic research, translating her academic groundwork into high-impact Antibiotic clinical methodologies.

Experience

Dr. Adelaida Lamas has held numerous clinical roles from pediatrician to consultant specialist in cystic fibrosis and pediatric pulmonology. Over three decades, she has directly engaged in Antibiotic regimen development, Antibiotic response analysis, and inpatient/outpatient Antibiotic monitoring. She has collaborated on national Antibiotic protocols and served as a senior advisor for pediatric Antibiotic clinical trials. She spearheaded multidisciplinary teams addressing Antibiotic efficacy in chronic lung infections. Her long-standing presence at the Ramón y Cajal University Hospital included management of patients under high-risk Antibiotic therapies. Her career reflects an unwavering commitment to maximizing Antibiotic utility through evidence-based approaches, influencing global Antibiotic practices.

Research Interest

Adelaida’s research focuses primarily on cystic fibrosis, pediatric lung diseases, and the development of advanced Antibiotic protocols. Her investigative work has examined the influence of inhaled and systemic Antibiotic agents on microbial resistance, with a special interest in Pseudomonas aeruginosa and MRSA strains. She has evaluated biofilm formation suppression using tailored Antibiotic therapies. Her publications address therapeutic challenges posed by Antibiotic resistance in CF patients. Additionally, she explores Antibiotic rotation strategies and novel delivery systems for pediatric populations. Her evolving research underscores Antibiotic relevance in chronic infection modulation, driving forward pediatric pulmonary care innovations via adaptive Antibiotic strategies.

Awards and Honors

Throughout her career, Adelaida has received national and international recognition for her work in Antibiotic research. She was awarded for her contributions to improving Antibiotic application in cystic fibrosis treatment. Her doctoral thesis earned the “Dra. Juana Román First Prize” for excellence in pediatric medicine and Antibiotic safety analysis. She served as principal advisor in the Spanish national Antibiotic positioning reports. As a respected voice in Antibiotic advisory boards and task forces, she influenced policy-making and regulatory evaluations of pediatric Antibiotic use. Her honors reflect a profound contribution to scientific understanding and clinical integration of Antibiotic therapies in respiratory medicine.

Research Skills

Adelaida’s skill set includes designing, conducting, and supervising Antibiotic trials and interventions for pediatric lung diseases. She employs techniques to evaluate Antibiotic resistance, optimize dosage, and analyze pharmacological responses. Her work integrates bioinformatics, molecular diagnostics, and microbiological cultures to assess Antibiotic impact in real time. She is adept in critically appraising clinical literature on Antibiotic therapy and translating findings into bedside protocols. Her proficiency in ethical evaluation of Antibiotic use in vulnerable groups is evident from her role in national ethics committees. These multidisciplinary capabilities solidify her role as a leader in Antibiotic clinical innovation and translational application.

Publications

  • Title: Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: Incidence and results of the national CF-COVID19-Spain survey
    Authors: P. Mondejar-Lopez, E. Quintana-Gallego, R.M. Giron-Moreno, et al.
    Journal: Respiratory Medicine, Vol. 170, Article 106062, 2020

  • Title: Insulin resistance, β-cell dysfunction and differences in curves of plasma glucose and insulin in the intermediate points of the standard glucose tolerance test in adults with cystic fibrosis
    Authors: M.C. Megías, O.G. Albarrán, P.G. Vasco, A.L. Ferreiro, L.M. Carro
    Journal: Endocrinología y Nutrición (English Edition), Vol. 62(2), Pages 91–99, 2015

  • Title: A comprehensive evaluation of omega-3 fatty acid supplementation in cystic fibrosis patients using lipidomics
    Authors: Ó. Pastor, P. Guzmán-Lafuente, J. Serna, M. Muñoz-Hernández, A.L. Neyra, et al.
    Journal: The Journal of Nutritional Biochemistry, Vol. 63, Pages 197–205, 2019

  • Title: Protocol for the diagnosis and follow up of patients with cystic fibrosis
    Author: S. Gartner
    Journal: Anales de Pediatría (Barcelona, Spain: 2003), Vol. 71(3), Pages 250–264, 2009

  • Title: Tolerance of two inhaled hypertonic saline solutions in patients with cystic fibrosis
    Authors: L.M. Carro, A.L. Ferreiro, M.R. de Valbuena Maiz, C.W. Struwing, G.G. Álvarez, et al.
    Journal: Medicina Clínica, Vol. 138(2), Pages 57–59, 2012

Conclusion

Adelaida Lamas remains an influential force in pediatric medicine, with her legacy deeply rooted in Antibiotic innovation. Her strategic insights and practical applications of Antibiotic therapies have improved care standards, particularly for cystic fibrosis patients. Her work bridges academic excellence and clinical precision, ensuring Antibiotic efficacy against evolving microbial threats. She is recognized not only for her scientific achievements but also for her mentorship in Antibiotic clinical research. Her enduring contributions ensure the continual advancement of Antibiotic science, affirming its central role in child health and respiratory care. Adelaida’s lifelong dedication to Antibiotic research sets a benchmark for future medical leaders.

Charlene Pillay – Antibiotic – Best Researcher Award

Charlene Pillay - Antibiotic - Best Researcher Award

Durban University of Technology - South Africa 

AUTHOR PROFILE

ORCID

🎓 EARLY ACADEMIC PURSUITS

Dr. Charlene Pillay’s academic journey began at the University of KwaZulu-Natal, where she pursued a passion for microbiology, culminating in a PhD in 2012. Her doctoral thesis focused on microbiologically influenced corrosion—an intersection of microbiology and material science—under the guidance of Professor Johnson Lin. This work explored the impact of nitrate sources on steel corrosion in simulated systems, laying a strong foundation for her future research interests. She earlier completed her MSc, BSc Honours, and BSc in Microbiology at the same institution. These academic milestones not only reflect her dedication but also shaped her into a specialist with deep-rooted scientific curiosity. Her early academic accomplishments were punctuated by significant research, blending microbiology with environmental and industrial applications. This robust educational background has since served as the bedrock of her teaching and research endeavors. Driven by curiosity and scholarly discipline, Dr. Pillay’s academic formation set the tone for a prolific scientific career.

👩‍🔬 PROFESSIONAL ENDEAVORS IN EDUCATION

Currently serving as a Senior Lecturer at Durban University of Technology (DUT), Dr. Charlene Pillay is deeply engaged in academic mentorship, curriculum development, and student supervision. Since 2015, she has delivered lectures, coordinated work-integrated learning, and facilitated essential industry-academic linkages. Her role extends beyond the classroom, involving the academic supervision of students placed in industrial settings, thus reinforcing experiential learning. Before joining DUT, she held various teaching and technical positions at the University of KwaZulu-Natal, including AdHoc Lecturer roles in Bacteriology and Advanced Bacteriology, and a stint as Laboratory Technician. These roles helped her develop both instructional expertise and technical skills crucial in laboratory education. Her teaching philosophy blends theory with hands-on experience, equipping students with a holistic understanding of microbiology. Through her academic contributions, she has established herself as a dynamic educator committed to nurturing future scientists and bridging academia with real-world applications in biosciences.

🧪 CONTRIBUTIONS AND RESEARCH FOCUS

Dr. Pillay’s research focus reflects a unique synergy between microbiology, corrosion science, and ethnopharmacology. Initially concentrated on microbiologically influenced corrosion, her scholarly journey evolved to include antimicrobial research, bioremediation, and computational drug discovery using traditional medicinal plants. She has supervised numerous Honours and Master’s research projects addressing diverse topics such as bacterial modulation, type 2 diabetes therapy, soil bioremediation, and plant-based antimicrobial agents. Her publication portfolio spans high-impact journals like Archives of Microbiology, BMC Genomics, and Metabolites, showcasing work on quorum sensing modulators, gut microbiome studies, and therapeutic validation of plant-derived compounds. Notably, her interdisciplinary investigations bridge computational modeling with in vitro validations. Dr. Pillay’s research significantly contributes to understanding microbial behavior, the utility of plant secondary metabolites in health, and sustainable biomedical solutions. Her work remains rooted in addressing real-world health challenges through science-driven innovation, positioning her as a leading voice in applied microbiological research.

🏆 ACCOLADES AND RECOGNITION

Dr. Charlene Pillay’s scholarly excellence has earned her multiple accolades that underscore her research impact and scientific promise. She received the prestigious Ivan Oligvie Award from the Corrosion Institute of Southern Africa in 2008 for her early work in corrosion science. In 2009, she was honored with the SASM-Bio2Biz Travel Award, followed by a local conference travel award from the Faculty of Science and Agriculture at UKZN in 2011. These recognitions mark pivotal moments in her career, affirming the quality and relevance of her research. Beyond formal awards, her consistent publication record in reputable scientific outlets and active participation in interdisciplinary research teams further validate her professional standing. Through her collaborative work with colleagues like Professors Sabiu and Lin, Dr. Pillay continues to earn respect in both academic and applied science spheres. Her accolades reflect not only academic merit but also her growing influence as a respected contributor in microbiological and biomedical sciences.

🌿 IMPACT THROUGH SCIENTIFIC INNOVATION

Dr. Pillay's research has profound implications for environmental sustainability and public health, particularly through her investigations into plant-based therapeutics and microbial ecology. By integrating traditional medicinal knowledge with modern cheminformatics, she contributes to the discovery of bioactive compounds with the potential to combat non-communicable diseases like diabetes. Her studies on plant secondary metabolites, such as flavonoids and phenolic acids, are pivotal in developing alternative therapeutic strategies. Likewise, her research into bacterial biofilms and quorum sensing provides critical insights into managing antimicrobial resistance. The environmental aspect of her work—focusing on biodegradation of contaminants and soil microbiome dynamics—highlights her commitment to ecological well-being. These innovative approaches not only advance scientific understanding but also propose sustainable, low-cost healthcare and environmental solutions. Her work inspires future scientists to pursue research with tangible societal benefits, thereby enhancing her broader impact across academic, medical, and ecological domains.

👥 MENTORSHIP AND SCHOLARLY INFLUENCE

As a postgraduate supervisor, Dr. Charlene Pillay has significantly shaped the next generation of microbiologists and biomedical researchers. Her mentorship extends to BTech, Honours, and Master's students, with projects spanning from bioremediation techniques to computational drug modeling. She is known for encouraging innovation and critical thinking, guiding students through complex scientific methods and interdisciplinary topics. Many of her mentees have focused on real-world challenges such as antimicrobial resistance, plant-based drug development, and gut microbiome studies. Her mentorship fosters independence and scientific rigor, qualities evident in the student theses she has overseen. Through these scholarly interactions, she cultivates a research culture grounded in curiosity, integrity, and relevance. Her influence extends beyond academia into healthcare and biotechnology industries via her well-trained graduates. This legacy of mentorship underscores her dual role as both educator and enabler, investing in people as passionately as she invests in scientific exploration.

🔮 LEGACY AND FUTURE CONTRIBUTIONS

Dr. Charlene Pillay envisions a legacy rooted in transformative science and inclusive education. Her ambition to become a full professor with a thriving cohort of successful postgraduates reflects her long-term dedication to academic leadership. With aspirations to secure major research funding, she aims to expand her work in ethnopharmacology and microbial pathogenesis, focusing on groundbreaking, plant-based interventions for global health challenges. Her evolving research portfolio suggests forthcoming contributions in personalized medicine, antimicrobial strategies, and microbial genomics. As a thought leader in integrating traditional knowledge with modern science, she continues to set new standards for interdisciplinary research. Dr. Pillay’s legacy is one of innovation, mentorship, and impact—building bridges between past wisdom and future science. Her future contributions are poised to influence not only academia but also public health policy, environmental management, and scientific education, making her a pivotal figure in the global scientific community.

NOTABLE PUBLICATION

Title: A metagenomic investigation of the faecal RNA virome structure of asymptomatic chickens obtained from a commercial farm in Durban, KwaZulu-Natal province, South Africa
Authors: Nwokorogu, Vivian C.; Pillai, Santhosh; San, James E.; Pillay, Charlene; Nyaga, Martin M.; Sabiu, Saheed
Journal: BMC Genomics (2024)

Title: Cheminformatics Identification and Validation of Dipeptidyl Peptidase-IV Modulators from Shikimate Pathway-Derived Phenolic Acids towards Interventive Type-2 Diabetes Therapy
Authors: Balogun, Fatai Oladunni; Naidoo, Kaylene; Aribisala, Jamiu Olaseni; Pillay, Charlene; Sabiu, Saheed
Journal: Metabolites (2022)

Title: Identification of Flavonoid C-Glycosides as Promising Antidiabetics Targeting Protein Tyrosine Phosphatase 1B
Authors: Rampadarath, Athika; Balogun, Fatai Oladunni; Pillay, Charlene; Sabiu, Saheed
Journal: Journal of Diabetes Research (2022)

Title: Poultry gut health - microbiome functions, environmental impacts, microbiome engineering and advancements in characterization technologies
Authors: Aruwa, Christiana Eleojo; Pillay, Charlene; Nyaga, Martin M.; Sabiu, Saheed
Journal: Journal of Animal Science and Biotechnology (2021)

Title: The impact of additional nitrates in mild steel corrosion in a seawater/sediment system
Authors: Pillay, Charlene; Lin, Johnson
Journal: Corrosion Science (2014)